Beyond Us Versus Them

od KLEMPNER, MARK S
Izdano 1999

Taking a Bite Out of Vector-Transmitted Infectious Diseases

od Klempner, Mark S., Unnasch, Thomas R., Hu, Linden
Izdano 2007

CD14 Mediates Cross Talk between Mononuclear Cells and Fibroblasts for Upregulation of Matrix Metalloproteinase 9 by Borrelia burgdorferi

od Zhao, Zhihui, Fleming, Rhonda, McCloud, Bilaal, Klempner, Mark S.
Izdano 2007

Association of Immune Response to Endothelial Cell Growth Factor With Early Disseminated and Late Manifestations of Lyme Disease but Not Posttreatment Lyme Disease Syndrome

od Tang, Kevin S., Klempner, Mark S., Wormser, Gary P., Marques, Adriana R., Alaedini, Armin
Izdano u Clin Infect Dis (2015)

Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic tolerance

od Vega, Nicole M., Allison, Kyle R., Samuels, Amanda N., Klempner, Mark S., Collins, James J.
Izdano 2013

Reply to Blair et al.: Dose-dependent effects and oxidative stress responses in antibiotic tolerance in Salmonella typhimurium

od Vega, Nicole M., Allison, Kyle R., Samuels, Amanda N., Klempner, Mark S., Collins, James J.
Izdano 2013

Analysis of Differences in the Functional Properties of the Substrate Binding Proteins of the Borrelia burgdorferi Oligopeptide Permease (opp) Operon

od Wang, Xing-Guo, Kidder, J. Michael, Scagliotti, Joanna P., Klempner, Mark S., Noring, Richard, Hu, Linden T.
Izdano 2004

Association between Human Leukocyte Antigen Class II Alleles and Genotype of Borrelia burgdorferi in Patients with Early Lyme Disease

od Wormser, Gary P., Kaslow, Richard, Tang, Jianming, Wade, Karen, Liveris, Dionysios, Schwartz, Ira, Klempner, Mark
Izdano 2005

A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life

od Souders, Colby A, Nelson, Stuart C, Wang, Yang, Crowley, Andrew R, Klempner, Mark S, Thomas, William
Izdano u MAbs (2015)

Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms

od Chandra, Abhishek, Wormser, Gary P., Klempner, Mark S., Trevino, Richard P., Crow, Mary K., Latov, Norman, Alaedini, Armin
Izdano 2010

Treatment Trials for Post-Lyme Disease Symptoms Revisited

od Klempner, Mark S., Baker, Phillip J., Shapiro, Eugene D., Marques, Adriana, Dattwyler, Raymond J., Halperin, John J., Wormser, Gary P.
Izdano 2013

IgA as a potential candidate for enteric monoclonal antibody therapeutics with improved gastrointestinal stability

od Wallace, Aaron L., Schneider, Matthew I., Toomey, Jacqueline R., Schneider, Ryan M., Klempner, Mark S., Wang, Yang, Cavacini, Lisa A.
Izdano u Vaccine (2020)

Structural and Molecular Analysis of a Protective Epitope of Lyme Disease Antigen OspA and Antibody Interactions

od Shandilya, Shivender, KurtYilmaz, Nese, Sadowski, Andrew, Monir, Ejemel, Schiller, Zachary A., Thomas, William D., Klempner, Mark S., Schiffer, Celia A., Wang, Yang
Izdano u J Mol Recognit (2016)

Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration

od Hu, Yue, Kumru, Ozan S., Xiong, Jian, Antunez, Lorena R., Hickey, John, Wang, Yang, Cavacini, Lisa, Klempner, Mark, Joshi, Sangeeta B., Volkin, David B.
Izdano u J Pharm Sci (2020)

Pre-exposure Prophylaxis With OspA-Specific Human Monoclonal Antibodies Protects Mice Against Tick Transmission of Lyme Disease Spirochetes

od Wang, Yang, Kern, Aurélie, Boatright, Naomi K., Schiller, Zachary A., Sadowski, Andrew, Ejemel, Monir, Souders, Colby A., Reimann, Keith A., Hu, Linden, Thomas, William D., Klempner, Mark S.
Izdano u J Infect Dis (2016)

Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection

od Giuntini, Serena, Stoppato, Matteo, Sedic, Maja, Ejemel, Monir, Pondish, Jessica R., Wisheart, Danielle, Schiller, Zachary A., Thomas, William D., Barry, Eileen M., Cavacini, Lisa A., Klempner, Mark S., Wang, Yang
Izdano u Infect Immun (2018)

Correction for Giuntini et al., “Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection”

od Giuntini, Serena, Stoppato, Matteo, Sedic, Maja, Ejemel, Monir, Pondish, Jessica R., Wisheart, Danielle, Schiller, Zachary A., Thomas, William D., Barry, Eileen M., Cavacini, Lisa A., Klempner, Mark S., Wang, Yang
Izdano u Infect Immun (2018)

Anti-OspA DNA-Encoded Monoclonal Antibody Prevents Transmission of Spirochetes in Tick Challenge Providing Sterilizing Immunity in Mice

od Wang, Yang, Esquivel, Rianne, Flingai, Seleeke, Schiller, Zachary A, Kern, Aurélie, Agarwal, Sangya, Chu, Jacqueline, Patel, Ami, Sullivan, Katherine, Wise, Megan C, Broderick, Kate E, Hu, Linden, Weiner, David B, Klempner, Mark S
Izdano u J Infect Dis (2019)

Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants

od Teh, Audrey Y-H, Cavacini, Lisa, Hu, Yue, Kumru, Ozan S., Xiong, Jian, Bolick, David T., Joshi, Sangeeta B., Grünwald-Gruber, Clemens, Altmann, Friedrich, Klempner, Mark, Guerrant, Richard L., Volkin, David B., Wang, Yang, Ma, Julian K-C.
Izdano u Gut Microbes (2021)

IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity

od Ejemel, Monir, Li, Qi, Hou, Shurong, Schiller, Zachary A., Wallace, Aaron L., Amcheslavsky, Alla, Yilmaz, Nese Kurt, Toomey, Jacqueline R., Schneider, Ryan, Close, Brianna J., Chen, Da-Yuan, Conway, Hasahn L., Mohsan, Saeed, Cavacini, Lisa A., Klempner, Mark S., Schiffer, Celia A., Wang, Yang
Izdano u bioRxiv (2020)